Sun, Apr 20, 2014, 7:03 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Acura Pharmaceuticals, Inc. Message Board

  • fyokuxco fyokuxco Jul 15, 2013 10:33 AM Flag

    Acura Pharmaceuticals to Develop Improved NEXAFED(R)

    ACUR announced a second generation prototype formulation of its methamphetamine-resistant IMPEDE technology with pseudoephedrine hydrochloride yielded no measurable amount of crystal meth. Got upgraded to strong buy at stoxline website.

 
ACUR
1.295+0.015(+1.17%)Apr 17 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.